PHIBRO ANIMAL HEALTH CORP
For the period ended Dec 31, 2025. Filed Feb 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 4, 2026
PAHC$34.61+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| · · · · · · | |||||
|---|---|---|---|---|---|
| · · December 31, · · June 30, | |||||
| As of · · 2025 · · 2025 | |||||
| · · (unaudited) | |||||
| · (in thousands, except share and per share amounts) | |||||
| ASSETS · · · · · · | |||||
| Cash and cash equivalents | | $55,486 | | $68,039 | |
| Short-term investments | | 19,022 | | 9,000 | |
| Accounts receivable, net | | 215,872 | | 227,983 | |
| Inventories, net | | 517,347 | | 444,425 | |
| Other current assets | | 54,458 | | 61,159 | |
| Total current assets | | 862,185 | | 810,606 | |
| Property, plant and equipment, net | | 355,381 | | 354,690 | |
| Intangibles, net | | 33,066 | | 36,469 | |
| Goodwill | | 59,814 | | 59,645 | |
| Other assets | | 95,107 | | 99,490 | |
| Total assets | | $1,405,553 | | $1,360,900 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
| Current portion of long-term debt | | $20,638 | | $16,250 | |
| Accounts payable | | 133,296 | | 138,201 | |
| Accrued expenses and other current liabilities | | 128,436 | | 139,022 | |
| Total current liabilities | | 282,370 | | 293,473 | |
| Revolving credit facility | | 107,000 | | 87,000 | |
| Long-term debt | | 603,602 | | 615,435 | |
| Other liabilities | | 80,220 | | 79,310 | |
| Total liabilities | | 1,073,192 | | 1,075,218 | |
| Commitments and contingencies (Note 9) | | | | | |
| Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,573,136 and 20,367,574 shares issued and outstanding at December 31, 2025 and June 30, 2025, respectively; 30,000,000 Class B shares authorized, 19,961,034 and 20,166,034 shares issued and outstanding at December 31, 2025 and June 30, 2025, respectively | | 4 | | 4 | |
| Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding | | — | | | — |
| Paid-in capital | | 137,768 | | 136,995 | |
| Retained earnings | | 316,959 | | 272,701 | |
| Accumulated other comprehensive loss | | (122,370) | | (124,018) | |
| Total stockholders’ equity | | 332,361 | | 285,682 | |
| Total liabilities and stockholders’ equity | | $1,405,553 | | $1,360,900 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.